Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US Read more
BeiGene Announces European Medicines Agency Acceptance of Marketing Authorization Applications for Tislelizumab for the Treatment of Patients with ESCC and NSCLC Read more
Exclusive Speaker Interview With Stefano Zanotti, Head of Neuromuscular Research at Dyne Therapeutics Read more
New data for Roche’s OCREVUS (ocrelizumab) show benefit in disability progression and cognitive decline in both secondary progressive and primary progressive multiple sclerosis Read more
FDA grants priority review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults Read more
CanSinoBIO’s COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China Read more
SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor Read more
Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder Read more
Novartis announces European Commission approval of Beovu for people living with diabetic macular edema Read more